Stacy D. D’Andre
WinnMed(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer survivorship and care, Immunotherapy and Immune Responses, Cannabis and Cannabinoid Research, Cancer Risks and Factors
Most-Cited Works
- → First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma(2018)531 cited
- → Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma(2022)373 cited
- → Effect of High Dose Vitamin C on Urinary Oxalate Levels(1994)110 cited
- → Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer WithERBB2Amplification orERBB2/3Mutations: Results From the TAPUR Study(2022)59 cited
- → A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.(2020)56 cited
- → 5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study(2005)42 cited
- → Pertuzumab plus trastuzumab (P+T) in patients (Pts) with colorectal cancer (CRC) with ERBB2 amplification or overexpression: Results from the TAPUR Study.(2020)41 cited
- → Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series(2021)26 cited
- → Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma(2018)17 cited
- → A randomized phase II non-comparative study of Ispinesib given weekly or every three weeks in metastatic colorectal cancer. A California Cancer Consortium Study (CCC-P)(2006)11 cited